ECHOMETRIX IS ADVANCING IMAGING
Use of MRI for the routine diagnosis of musculoskeletal conditions in the U.S. will cost $2.5 billion by 2020. Echometrix’s advancements in ultrasound technology for the evaluation of musculoskeletal (MSK) conditions will help to solve this problem by making ultrasound easier to use by a variety of treating clinicians.
Increasingly, ultrasound is being used for musculoskeletal diagnosis, but the challenge is that no standard approach exists. Echometrix is meeting this unmet clinical need with EchoSoft™ tissue analysis module, which enables improvements to soft tissue diagnosis and management:
- Provide objective measures at diagnosis and during the healing process (i.e., strained vs. torn differential diagnosis)
- Available at the point of care
- Exams are one-third the cost of MRI
- Usable by all trained treating physicians
Ultrasound equipment miniaturization, cost reduction, and improvements in image quality have dramatically expanded the useful applications for ultrasound in healthcare. One of the least-penetrated markets for ultrasound is musculoskeletal, and major players in the ultrasound industry are very focused on this market, although they lack the technological advantage offered by Echometrix.